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ABSTRACT 
Despite as high price consumption fish, humpback grouper grow out take very long time so its 
culture considered not efficient. Therefore to accelerate its growth rate and make grow out 
culture more efficient, recombinant Epinepheluslanceolatus growth hormone (rElGH) was applied 
by oral route. Daily application of rough rElGH at a dose of 5 mg/100 g commercial diet for 
42 days resulted significance increase in growth rate compared to control groups. No specific 
histological damage on kidney, liver and spleen which was attributable to rElGH 
administration. These results strongly suggested that growth stimulation following oral 
administration was due to a specific action of rElGH and recombinant GH as mentioned above 
save for fish consumption.  
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INTRODUCTION 
Growth hormone (GH)is one of polypeptide hormone contain nearly 200 amino acids, 
produced and secreted by somatotroph cells of vertebrate anterior pituitary gland. This 
hormone has two major actions: (1) direct metabolic effects that facilitatemuscle growth and 
glucose sparing and (2) skeletal growth effects that arepartially direct and partially mediated 
by IGF-I (Bolander 2004). More recently several authors stated that GH participated in nearly 
all main physiologic processes such as ionic and osmotic regulation; protein, lipid and 
carbohydrate metabolisms as well as reproduction and immune (Reinecke et al., 2005; 
Birzniece et al., 2009; Hattori, 2009). 
Within the last 3 decades, the growth promoting effects of GH have been well 
documented in a variety of species of fish either as endogenous or exogenous 
hormone(Donaldson et al., 1979; Moriyama and Kawauchi, 2001). Studies investigating the 
use of recombinant growth hormone (rGH) for promoting growth in salmonids  (Sekine et al., 
1985; Moriyama, 1995), rainbow trout (Moriyama et al., 1993), red seabream (Bin et 
al.,2001), flounder (Liu et al.,2008), tilapia (Li et al., 2003; Acosta et al., 2007), rabbitfish 
(Funkenstein et al., 2005), goldfish (Promdonkoy et al., 2004), black seabream (Tsai et al., 
1997), Indonesian eel (Handoyo, 2012), giant gourami (Irmawati, 2013) and many others 
species found that rGHable to accelerate thegrowth. Donaldson et al. (1979) suggested that 
exogenous GH enhances fish growth by stimulating appetiteand then improving feed and 
protein conversion; while Silverstein et al. (1999) suggested GH might stimulate food intake 
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indirectly through metabolic changes such as increased utilization of nutrients that feedback on 
hypothalamic centers regulating energy balance. 
Regarding to the potential food safety and environmental safety issues associated with 
transgenic fish (Muir and Howard, 1999), the use of transgenic organism to produce rGHfor 
increasing yields in aquaculture has generated considerable interest (Leedom et al., 
2002).One method that could be used to verify the safety of exogenous substances in target 
organism is histopathological examination as were done byFarris et al. (2007), Liu et al. 
(2008) and Irmawati (2013). 
While the advantage of rGH was studied elsewhere for various species, no one study 
was done to humpback grouper. This species is one of major marine fish consumption culturing 
in Indonesia, and has high price but very low growth rate. In the present study, for the first 
time we studied the effect of rGH on growth, survival, feed efficiency, muscle composition and 
histology of liver, spleen and kidney of the humpback grouper juvenile. Liver, spleen and 
kidney are vital organs for vertebrate, subsequently serve as major role in metabolism, natural 
filter of the blood and remove wastes, and immune system. The objectivesof this study were to 
verify the effectiveness and the safety of rGHas feed additive to promote growth of the 
species studied. 
MATERIALS AND METHODS 
1. Production of protein rElGH and preparation of feed 
Escherichia colistrain BL21 harboring pCold-ElGHprotein expression vectorwas used as 
bioreactor for producing rElGH.Bacteria culture, extractionand verification of protein rElGH 
were done according to Alimuddin et al. (2010).To protect rElGH from proteolitic digestive 
enzyme, the protein was coated by hydroxypropylmethyl cellulose phthalate (HP55, Shinetsu, 
Japan) as described by Moriyama et al.(1993) before it mixed with commercial diet (CD).  
 
2. Experimental design 
The experiment was conducted for 42 days with five treatment groups; (1) C- or control 
negative (fed with CD), (2) C+ or control positive (CD with placebo), (3) pA(CDwith 0.2 mg 
rElGH-HP55/100 g feed), (4) pB (CDwith 1 mg rElGH-HP55/100 gfeed) and (5) pC (CD with 
5 mg rElGH-HP55/100 g feed).The serial doses was found from preliminary test.CD was 
bought from Japanese Company contains approximately 48.70 % crude protein and 13.30% 
crude lipid. 
3. Fish husbandry and experimental protocol 
Humpback grouper juveniles (body weight 1.44±0.30 g)obtained from Main Center for 
Mariculture Development, Lampung, Directorate General of Aquaculture, Ministry of Marine 
and Fishery, were randomly distributed into15 buckets (45 x 45 x 45 cm),50 fish per 
bucket,3buckets per treatment group. Each bucket in the same treatment group was fitted in 
2000-Lfiber glass tank respectively.They were fed with CD and acclimatized to the 
 
 193 
experimentalconditions for 1 week. Fishes were reared under natural photoperiod and 
suppliedwith sand-filtrated seawater continuously. The watertemperature (28–29.0 °C), 
salinity (31–32‰), pH (8.0–8.5) and dissolved oxygen level (5-6 mg/l) of the water 
weremonitored routinely and maintained within the limits. Uneaten feed, feces and other dirties 
were siphoned daily. Fish were hand fed three times a day (at 08:30; 12:30 and 16.30) 
toapparent satiation. The amount of feed consumed (FC) in each bucketaccording to the 
treatment groups and the number as well as weight of fish died were recorded daily. Total 
body weight of fish were measured once time per 2 weeks. 
4. Chemical analysis of body muscle 
At the end of the 42 days trial, body muscles of 3 fish in each aquarium weredissected 
and pooled together for proximate analysis of muscle. Specimens ofmuscle were 
homogenized, 5 g aliquot was oven-dried to constant weight at105 °C to estimate the 
moisture content, while the remaining samples werelyophilized and stored at −20 °C for 
chemical analysis. Kjeldahl and HCl hydrolysis methods were employed to determine the 
protein and lipid content,respectively.  Protein, lipidand moisture content in each sample were 
determined in triplicate. 
The content of muscle and liver glycogen were determined by multiplication of absorbent 
sample with mg/ml dilution then divide by absorbentstandard. Absorbent sample was 
obtained from a serial process which was involved heating, centrifugation, hydrolysis and 
measuring absorbent value by spectrophotometer. Spectrophotometer was also used for 
measure plasma glucose.  
5. Histological study 
At the end of feeding trial, samples of liver, spleen andkidney were taken from 3 fish 
from control groups and best dose respectively, for histopathological evaluation. Liver of all 
fishin each group was weighed for the determination of hepatosomatic index.All samples were 
fixed in fixative buffered formalin, dehydrated in agraded ethanol series, embedded in 
paraffin and sectioned to 4μm with a rotarymicrotome. Sections were stained with 
haematoxylin and eosin (H&E) andobserved under light microscope. 
6. Calculations and statistical analysis 
Specific growth rate (SGR) was calculated as (lnW2−lnW1)×100/time, survival (SR) was 
Nt/N0 x 100, feed efficiency (FE)was calculated as (W2+WD)-W1/feed 
consumedx100,∆Wwas difference between W2 and W1, protein retention (PR) was 
calculated as Pbt - Pb0/Pc x 100 and lipid retention (LR) was calculated as Lbt – Lb0/Lc x 
100. W2, W1,WD, Nt, N0,Pbt, Pb0,Lbt and Lb0 are represent final body weight, initial body 
weight, died body weight, final number, initial number, final protein body,initial protein body, 
final lipid body and initial lipid body of fish, respectively; while Pc and Lcsuccessively 
represent as protein consumed and lipid consumed. Hepatosomatic index (HSI) was calculated 
as liver weight×100/body weight. All data between treatment groups were analyzed by 
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one-way ANOVA, followed by Duncan's Multiple Range Test of Significance. Difference was 
regarded as significant when P<0.05. 
RESULTS AND DISCUSSION 
Fish growth performance was presented in Table 1.Although during the 42 days trial 
there were some fish died in C+, pB and pC but the survival rate (SR) differences among 
experimental groupswere not significant. Final body weight (W2), SGR, FC and FE of the 
rGHtreatment groups were significantly different than two control groups; however the 
difference between two control groups were not significant. These results indicated that the 
growth-promoting effect was caused by rElGH, not by the placebo itself.∆Wof pA, pB and 
pCsubsequently were 23.69 %, 31.45 % and 40.25 %higher than ∆Wof C-. The figure of 
pCwas highest than other experimental groups, it isindicated that the dose for pCwas better 
than pB and pA. 
Table 1. Effect of rElGH on survival, growth, feed consumed and feed efficiency of 
humpback grouper juvenile. 
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Different superscript letter in the same column indicated significant difference based on Duncan 
test (P<0.05).  
It is the first study revealed that feeding rElGHcould significantly stimulate the growth of 
humpback grouper. Other study related with rElGH was done by Handoyo (2012) to 
Indonesian eel fingerling by immersion, oral route and combination of immersion and oral; 
increasing growth subsequently as big as 37.4 %, 65.7 % and 102.9 % higher than control. 
Same application methods were used by Subaidah (2013) for whiteshrimp, the growth of 
rElGHtreatment group were 109.9 %, 17.7 % and 40.1 % respectively higher than control. 
Other studies also demonstrated the efficiency of oral administrated rGHs in promoting fish 
growth. Moriyama et al. (1993) reported that feeding recombinant salmon GH caused 
significant increase in body weight and length of rainbow trout. Oral delivery of recombinant 
fish GH induced a 1.6-fold increase in body weight of black seabream (Tsai et al., 
1997).Promdonkoy et al. (2004) used rGH from giant catfish to goldfish by oral delivery 
found increasing body weight 84 % higher than control. Despite the proteolytic enzymes in the 
gastrointestinal tract of fish could hydrolyze oral administrated GH, the present result along 
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with the cited reports above clearly demonstrated that dietary delivery of rGHin form of rGH 
coated HP55is an effective approach to enhance fish growth. 
As mentioned earlier, exogenous GH may enhances fish growth by stimulating appetite 
then increasing feed consume and improving feed conversion (Donaldson et al., 1979; 
Silverstein et al., 1999). This study showed that after consuming rGH, growth rate, and 
appetite/feed consume and feed efficiency of humpback grouper significantly higher than 
control groups (Table 1). It isconsistent with study result ofMarkert et al. (1977) in salmonids, 
Wilson et al.(1988) and Silverstein et al. (2000) in channel catfish. Reversely Liu et al. (1999; 
2008) found different result, feeding recombinant GH to flounder could promote fish growth 
and improve feed conversion, but did not affect feed intake. GH might stimulate food intake 
indirectly through metabolic changes such as increased utilization of nutrients that feedback on 
hypothalamic centers regulating energy balance (Silverstein et al., 1999). One of 
hypothalamic factors which may involve to regulate energy balance is ghrelin, where GH and 
ghrelin working together in a 2 ways mechanism (Wong et al., 2006). Further investigations 
are needed to verify relation between GH and ghrelin in promoting growth and feed 
consumption. 
Table 2. Proximate composition of body muscle, liver and muscle glycogen, and plasma 
glucose of humpback grouper juvenile after 42 days trial. 








C - 16,89+0,34a 5,85+0,16a 2,69+0,29a 4,11+0,51a 4.99+0.58a 55,78+13,10a 
C + 16,38+0,64a 6,16+0,23a 2,49+0,37a 4,44+0,45a 3.32+1.46a 41,53 + 5,86a 
pA - - - - - 58,86+12,79a,b 
pB - - - - - 59,65+15,48a,b 
pC 19,32+0,53b 6,22+0,10a 2.81+0,10a 5,56+0,31b 3,77+0,56a 81,95+12,85b 
Different superscript letter in the same column indicated significant difference based on Duncan test (P<0.05). 
Table 3. Hepatosomaticindex (HSI), protein retention (PR) and lipid 
retention (LR) of humpback grouper juvenile after 42 days trial. 
Group HSI PR LR 
C - 2,99 + 0,76 a 3,23+0,69a -0,07+0,79a 
C + 3,71 + 0,31 a 2,18+1,30a 1,00+0,88ab 
pA 4,46 + 1,29 a,b - - 
pB 4,89 + 1,21 b - - 
pC 5,45 + 0,80 b 8,21+1,08b 2,03+0,68b 
Different superscript letter in the same column indicated significant difference 
based on Duncan test (P<0.05). 
Protein content,liverglycogen and plasmaglucosefrom rGH treatment (represent by pC) 
were significantly higher than both control groups. Eventhough lipid and carbohydrate content 
have tendency higher than control but statistically not different as well as muscle 
glycogen(Table 2). These findings were consistent that GH has direct metabolic effects 
including the stimulation of lipolysisand protein synthesis which were especially pronounced in 
muscle. GH also has diabetogenetic effect, that is induces peripheral resistance to insulin such 
that glucose cannot be used and blood glucose levels rise then increasing liver glycogen 
deposit (Bolander, 2004).Hepatosomatic index and protein retention were significantly higher 
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than control whereas lipid retention significantly different than C – but if compare with C + not 
different (Table 3). A study in cohosalmon transgenic GH showed that GH able to increase HSI 
value 1.3 higher than control (Leggatet al., 2009).It has been known that the receptor of GH in 
fish mainly distributed in liver cells and liver is a main organ for GH to stimulate IGF-1 
production (Moriyama and Kawauchi, 2001); therefore as a consequence of increasing IGF-1 
production and other anabolic and katabolic metabolism GH treated organism needbigger 
size and capacity of liver. 
Many studies have investigated the effect of rGH on fish body compositionspecifically on 
protein and lipid content. Silverstein et al. (2000) found that recombinant bGH injection 
induced protein and lipid content in USDA-103 and Norris strain of channel catfish. Whereas, 
Peterson et al. (2004) observed no effect of recombinant bGH injection on body composition 
in NWAC103 and Norris strain of channel catfish. According to Liu et al. (1999), crude protein 
and crude fat content of muscle in flounder were increased by feeding recombinant yeast 
containing salmon GH.However, Liu et al. (2008) reported that protein and lipid content in 
muscle of flounder were not changed by feeding GH transgenic SYN. Different result was 
reported on giant gourami after treated with rGH, where lipid of treated fish was significantly 
lower than control groups. Investigation related to the lipid content showed that lipase enzyme 
activity in rGH treatment fish was higher than control (Irmawati, 2012). Protein and lipid 
content after feeding rGH are interesting topics for discussion;generally protein content is a 
desirable whereas lipid content is not desirable for commercially consumption fish cultured. 
Although fish size, age, diet and some experimental factors can affect to the body 
composition, the main cause for the different results obtained by different authors may more 
likely be the different responses to rGH treatment from different fish species and hormone 
dose used in experiments (Liu et al., 2008). Silverstein and Plisetskaya (2000) stated that the 
potential increasing body fatness after growth hormone treatment should be viewed with 
caution because increased body fat in juvenile fish may reduce feed intake for long time. 
Histological examination showed that no apparent differences in the appearance of liver, 
kidney and spleen tissue of C - and pC (Figure 1 and 2). There were some histological 
abnormalities found in all organs studied from both experimental groups such as inclusionbody 
acidophilic,necrosis, hemorrhage, fatty degeneration, hydropicdegeneration, hyaline 
degeneration and melano macrophage center. Based on routine check in our laboratory, the 
appearance of inclusion body acidophilicindicating that experimental fishes from all treatment 
infected by iridovirus. Meanwhile, another cell abnormalities caused by several infectious and 
non-infectiousdiseases had been reported (Medlineplus Encyclopedia, 2013; Kurtovic et al., 
2008; Agius and Roberts, 2003).Even though not clear what is the main cause of cell 
abnormalities in humpback grouper, since no specific histological damage which was 
attributable to rGH treatment group then it could be say that rGH consumption is safe for fish. 
This finding was consistent with several studies conducted before, such as by Liu et al. (2008) 
on flounder and Irmawati (2013) on giant gouramiwhich were found that rGH consumption 
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didn’t cause any specific histological damage for fish internal organs. In human clinical 
experience, rGH consumption replacement therapy for long time indicating a lack of 
convincing evidence for an increased risk of cell abnormalities (Farris et al., 2007). However, 
quantitative histological study still needed to elucidate the safety of rGH consumption in fish 







The study result clearly demonstrated that rGH from Epinepheluslanceolatusgene could 
enhanced the growth of humpback grouper and rElGH administration by oral delivery to be 
an effective method and lookedto be an economically viable feed additive for fish culture at 
commercial scale. This study alsorevealed that rGH consumption has no negative effects 
onsurvival, muscle composition and histology of fish studied. However, as ourconclusions were 
based on a 6-week feeding trial,further investigations using other fish species, long-
termfeeding experiment and quantitative histology examination should be undertaken to 
further confirm thegrowth-promoting effect and safety as feed additive of rGH. 
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